1-3 of 3
Samantha Langford
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Relapse Prophylaxis Post-Haploidentical Bone Marrow Transplantation and Cyclophosphamide (Haplo/Cy) By Infusion of Donor-Derived Expanded/Activated Gd T Cells: A Phase I Trial

Joseph P. McGuirk, Sunil H Abhyankar, Trishna Goswami, Rupal Soder, Mariska ter Haak, Tyce Bruns, Samantha Langford Youngblood, Lawrence S. Lamb, Jr.
Journal: Blood
Blood (2022) 140 (Supplement 1): 7464–7465.
https://doi.org/10.1182/blood-2022-169819
Published: 2022
Journal Articles

First-in-Human Phase I Trial of Adoptive Immunotherapy with Ex Vivo Expanded and Activated Γδ T Cells Following Haploidentical Bone Marrow Transplantation and Post-BMT Cyclophosphamide

Lawrence S. Lamb, Jr., PhD, Melissa Jo Beelen, Mjbeelen@incysus.com, Samantha Langford Youngblood, BS, Rupal Soder, PhD, Sunil Abhyankar, MD, Joseph P. McGuirk, DO
Journal: Blood
Blood (2020) 136 (Supplement 1): 9.
https://doi.org/10.1182/blood-2020-142876
Published: 2020
Journal Articles

Immune Reconstitution and Chimerism in Allogeneic HSCT Patients Treated with Post-HSCT High Dose Cyclophosphamide As Prophylaxis Against GvHD

Paluri k Ravi, Samina Karim, Gretchen Cloud, Mary Lamb, Samantha Langford, Shin Mineishi, MD, Racquel-innis Shelton, Ayman Saad, MD, Donna Salzman, MD, Lawrence S. Lamb, PhD
Journal: Blood
Blood (2014) 124 (21): 2474.
https://doi.org/10.1182/blood.V124.21.2474.2474
Published: 2014